Benzinger, Tammie L. S.
Washington University in St. Louis
73 papers on CoChatORCID 0000-0002-8114-0552
Most cited papers
- Verified
Preferential degradation of cognitive networks differentiates Alzheimer’s disease from ageing
Chhatwal, J. P., Schultz, A. P., Johnson, K. A., Hedden, T., Jaimes, S., Benzinger, T. L. S., Jack, C., Ances, B. M., Ringman, J. M., Marcus, D. S., et al. (2018) · Brain
Functional Brain Connectivity StudiesDementia and Cognitive Impairment Research
Cited by 101
- Verified
Amyloid-Related Imaging Abnormalities: An Update
Roytman, M., Mashriqi, F., Al-Tawil, K., Schulz, P. E., Zaharchuk, G., Benzinger, T. L. S., & Franceschi, A. M. (2023) · American Journal of Roentgenology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 99
- Verified
NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers
Vos, S. J. B., Gordon, B. A., Su, Y., Visser, P. J., Holtzman, D. M., Morris, J. C., Fagan, A. M., & Benzinger, T. L. S. (2016) · Neurobiology of Aging
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 98
- Verified
Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions
Strain, J. F., Smith, R. X., Beaumont, H., Roe, C. M., Gordon, B. A., Mishra, S., Adeyemo, B., Christensen, J. J., Su, Y., Morris, J. C., et al. (2018) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 97
- Verified
Neuropathologic assessment of participants in two multi‐center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)
Cairns, N. J., Perrin, R. J., Franklin, E. E., Carter, D., Vincent, B., Xie, M., Bateman, R. J., Benzinger, T., Friedrichsen, K., Brooks, W. S., et al. (2015) · Neuropathology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 86
- Verified
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer’s disease
Lim, Y. Y., Hassenstab, J., Cruchaga, C., Goate, A., Fagan, A. M., Benzinger, T. L. S., Maruff, P., Snyder, P. J., Masters, C. L., Allegri, R., et al. (2016) · Brain
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 76
- Verified
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
for the Dominantly Inherited Alzheimer Network (DIAN), Twohig, D., Rodriguez-Vieitez, E., Sando, S. B., Berge, G., Lauridsen, C., Møller, I., Grøntvedt, G. R., Bråthen, G., Patra, K., et al. (2018) · Acta Neuropathologica Communications
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 68
- Verified
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology
Morris, J. C., Weiner, M., Xiong, C., Beckett, L., Coble, D., Saito, N., Aisen, P. S., Allegri, R., Benzinger, T. L. S., Berman, S. B., et al. (2022) · Brain
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 68
- Verified
Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease
Wang, Q., Wang, Y., Liu, J., Sutphen, C. L., Cruchaga, C., Blazey, T., Gordon, B. A., Su, Y., Chen, C., Shimony, J. S., et al. (2019) · NeuroImage: Clinical
Advanced Neuroimaging Techniques and ApplicationsDementia and Cognitive Impairment Research
Cited by 63
- Verified
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
Su, Y., Blazey, T. M., Owen, C. J., Christensen, J. J., Friedrichsen, K., Joseph-Mathurin, N., Wang, Q., Hornbeck, R. C., Ances, B. M., Snyder, A. Z., et al. (2016) · PLOS ONE
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 56
- Verified
Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials
Lu, M., Pontecorvo, M. J., Devous, M. D., Arora, A. K., Galante, N., McGeehan, A., Devadanam, C., Salloway, S. P., Doraiswamy, P. M., Curtis, C., et al. (2021) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 56
- Verified
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study
Boerwinkle, A. H., Gordon, B. A., Wisch, J., Flores, S., Henson, R. L., Butt, O. H., McKay, N., Chen, C. D., Benzinger, T. L. S., Fagan, A. M., et al. (2023) · The Lancet Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 55
- Verified
Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study
Xiong, C., Jasielec, M. S., Weng, H., Fagan, A. M., Benzinger, T. L. S., Head, D., Hassenstab, J., Grant, E., Sutphen, C. L., Buckles, V., et al. (2016) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 54
- Verified
Importance of CSF-based Aβ clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways
Elbert, D. L., Patterson, B. W., Lucey, B. P., Benzinger, T. L. S., & Bateman, R. J. (2022) · Communications Biology
Alzheimer's disease research and treatmentsCerebrospinal fluid and hydrocephalus
Cited by 53
- Verified
The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study
Paranjpe, M. D., Chen, X., Liu, M., Paranjpe, I., Leal, J. P., Wang, R., Pomper, M. G., Wong, D. F., Benzinger, T. L. S., & Zhou, Y. (2019) · NeuroImage: Clinical
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 51
- Verified
Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults
Albrecht, D. S., Sagare, A., Pachicano, M., Sweeney, M. D., Toga, A., Zlokovic, B., Chui, H., Joe, E., Schneider, L., Morris, J. C., et al. (2021) · Brain, Behavior, and Immunity
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 37
- Verified
Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life Span
Luo, J., Ma, Y., Agboola, F. J., Grant, E., Morris, J. C., McDade, E., Fagan, A. M., Benzinger, T. L. S., Hassenstab, J., Bateman, R. J., et al. (2023) · Neurology
Dementia and Cognitive Impairment ResearchCerebrovascular and genetic disorders
Cited by 35
- Verified
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia
Llibre-Guerra, J. J., Fernandez, M. V., Joseph-Mathurin, N., Bian, S., Carter, K., Li, Y., Aschenbrenner, A. J., Pottier, C., Sigurdson, W., McDade, E., et al. (2025) · Nature Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 28
- Verified
Genetic and clinical correlates of AI-based brain aging patterns in cognitively unimpaired individuals
Skampardoni, I., Nasrallah, I. M., Abdulkadir, A., Wen, J., Melhem, R., Mamourian, E., Erus, G., Doshi, J., Singh, A., Yang, Z., et al. (2024) · JAMA Psychiatry
Dementia and Cognitive Impairment ResearchFunctional Brain Connectivity Studies
Cited by 28
- Verified
In vivo [ 18 F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease
Day, G. S., Gordon, B. A., Perrin, R. J., Cairns, N. J., Beaumont, H., Schwetye, K., Ferguson, C., Sinha, N., Bucelli, R., Musiek, E. S., et al. (2018) · Neurology
Prion Diseases and Protein MisfoldingDementia and Cognitive Impairment Research
Cited by 26
- Verified
Proteomic clusters underlie heterogeneity in preclinical Alzheimer’s disease progression
Wisch, J. K., Butt, O. H., Gordon, B. A., Schindler, S. E., Fagan, A. M., Henson, R. L., Yang, C., Boerwinkle, A. H., Benzinger, T. L. S., Holtzman, D. M., et al. (2023) · Brain
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 11
- Verified
Regional variability in Alzheimer's disease biomarkers
Gordon, B. A., Blazey, T., & Benzinger, T. L. (2014) · Future Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 11
- Verified
Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment
Chen, C. D., Ponisio, M. R., Lang, J. A., Flores, S., Schindler, S. E., Fagan, A. M., Morris, J. C., & Benzinger, T. L. S. (2023) · Journal of Alzheimer’s Disease
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 10
- Verified
Decoding brain structure to stage Alzheimer's disease pathology in Down syndrome
Kennedy, J. T., Wisch, J. K., Dincer, A., Roman, J., Gordon, B. A., Handen, B., Benzinger, T. L. S., Head, E., Mapstone, M., Christian, B. T., et al. (2025) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchDown syndrome and intellectual disability research
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free